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Advances in cellular therapies have led to the development of new approaches for
cell product purification and formulation, e.g., utilizing cell endogenous properties
such as size and deformability as a basis for separation from potentially harmful
undesirable by-products. However, commonly used additives such as Pluronic F-68
and other poloxamer macromolecules can change the mechanical properties of cells
and consequently alter their processing. In this paper, we quantified the short-term
effect of Pluronic F-68 on the mechanotype of three different cell types (Jurkat
cells, red blood cells, and human embryonic kidney cells) using real-time deform-
ability cytometry. The impact of the additive concentration was assessed in terms
of cell size and deformability. We observed that cells respond progressively to the
presence of Pluronic F-68 within first 3 h of incubation and become significantly
stiffer (p-value < 0.001) in comparison to a serum-free control and a control con-
taining serum. We also observed that the short-term response manifested as cell
stiffening is true (p-value < 0.001) for the concentration reaching 1% (w/v) of the
poloxamer additive in tested buffers. Additionally, using flow cytometry, we
assessed that changes in cell deformability triggered by addition of Pluronic F-68
are not accompanied by size or viability alterations. Published by AIP Publishing.
https://doi.org/10.1063/1.5040316
I. INTRODUCTION
The cell therapy market is expected to grow rapidly in the next few decades, leading to an
urgent need for new industry compatible cellular processes (Mason et al., 2011; Rao, 2011;
Heathman et al., 2015; Ahrlund-Richter et al., 2009; Preti, 2005; Parson, 2006; and Dodson
and Levine, 2015). However, several challenges arise when basic operations, such as product
purification, are scaled-up (Soares et al., 2014). As examples, Fluorescent Activated Cell
Sorting and Magnetic Activated Cell Sorting (FACS and MACS, respectively) are well-
established procedures for cell purification, but these techniques rely on expensive protein
labels and have a limited throughput (ml/h) (Jan Kr€uger, 2002 and Cho et al., 2010). Various
microfluidic-based systems are emerging as label-free alternatives to sort cells at a higher
throughput (ml/min), using inertial focusing (Di Carlo et al., 2007; Wang et al., 2013; Miller
et al., 2016), deterministic lateral displacement (Davis et al., 2006 and Huang et al., 2004),
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pinch flow fractionation (Yamada et al., 2004), or hydrodynamic filtration (Matsuda et al.,
2011) to mention a few. These approaches commonly consist of a micrometer size channel
where cells’ endogenous properties (i.e., size and/or deformability) are exploited for separation
in a continuous manner. One of the remaining bottlenecks with such microsystems is their ten-
dency to clog (Yoon et al., 2016 and Dressaire and Sauret 2016) due to the channel cross-
section being merely larger than a couple of cell diameters. One of the most commonly
accepted solutions to prevent clogging issues is the use of additives such as poloxamers, dex-
tran, or methylcellulose (Chisti, 2000).
Among these additives, Pluronic F-68 is a biocompatible amphiphilic and nonionic compound
consisting of a central polyoxypropylene (POP) block, flanked on both sides by hydrophilic chains
of polyoxyethylene (POE) (Alexandridis and Alan Hatton, 1995). This surface-active macromole-
cule (molecular weight, 8400) is used as an antifoam agent in stirred cell culture vessels and large
scale bioreactors (Goldblum et al., 1990; Karleta et al., 2010; and Tharmalingam et al., 2008)
among numerous other applications [e.g., as antithrombotic (O’Keefe et al., 1996) or anti-
inflammatory (Harting et al., 2008) agents, an artificial blood emulsifier (Schmolka, 1975), or a
skin wound cleanser (Rodeheaver et al., 1980)].
Pluronic F-68 and other poloxamers have been adopted as coating agents and additives in
microfluidic systems engineered for cell analysis (McClain et al., 2003), lysis (Hargis et al.,
2011), separation (Tan et al., 2013), and detection (Brouzes et al., 2009), in microconstrictions
for assessing cell mechanical properties (Lange et al., 2017) and digital microfluidics (Luk
et al., 2008). Poloxamers added to a flow buffer can coat glass (Tan et al., 2004), silicon
(Sundblom et al., 2010), Polydimethylsiloxane (PDMS) (Wong and Ho, 2009), and Poly(methyl
methacrylate) (PMMA) (Son et al., 2014)—materials commonly used for microfluidic fabrica-
tion. This kind of treatment prevents clogging, reagent adsorption, protein fouling, and cell-cell
interaction, reduces electro-osmotic flow, and can provide cell protection against a high degree
of shear stress (Au et al.,2011). This repair and protective mechanism of Pluronic on cells is
not fully understood yet; however, some literature evidence suggests the direct interaction with
the cell membrane causing cell stiffening (Maskarinec et al., 2002 and Wu et al., 2004). As
mentioned previously, mechanical cell properties are seen as a potential marker for label-free
separation with applications in large-scale bioprocessing. However, the observation that
Pluronic can stiffen cells suggests that the use of such additives could potentially impact the
performance of mechanical based purification approaches.
In this work, we investigated the effect of Pluronic F-68 on cells commonly used in micro-
fluidic studies: Jurkat cells, red blood cells (RBCs), and human embryonic kidney (HEK) cells.
The aim was to quantify if the addition of Pluronic F-68 significantly influenced the cell
mechanotype, which would have implications for mechanical phenotype based downstream
cellular processing. For the first time, observed changes were quantified using real-time deform-
ability cytometry (RT-DC) (Otto et al., 2015) to assess the short-term impact of Pluronic F-68,
in comparison to controls with and without serum, at high-throughput (thousands events/min).
II. MATERIALS AND METHODS
A. Real-time deformability cytometry
Cell mechanical properties were assessed using a Real-Time Deformability Cytometer (RT-
DC) as described in previous works (Mietke et al., 2015; Otto et al., 2015; and Xavier et al.,
2016). Briefly, a PDMS channel consisting of three sections, two reservoir sections and one
constriction channel (20lm  20 lm cross section), where cells undergo deformation and mea-
surements, are undertaken (SFig. 1). Cells were pumped into the channel at two different flow
rates of 0.04 (Jukrat and HEK) and 0.12 (red blood cells) ll/s, generating a shear stress (corre-
sponding to approximately 1.2 and 4 kPa, respectively), resulting in cell deformation. The RT-
DC system employs image processing algorithms which enable the measurement of the cell
area and deformation. Deformation ðD) is expressed as a deviation from a perfect circle
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D ¼ 1 c; (1)
where c is the circularity which is defined as
c ¼ 2
ﬃﬃﬃﬃﬃﬃ
pA
p
=l; (2)
with A being the projected cell area and l the cell perimeter. Deformation in the channel is
independently measured from the initial cell shape and therefore any treatment-induced mor-
phological changes to shape. Consequently, a differential deformation (DD) parameter has been
introduced (Herbig et al., 2018). DD includes morphological information acquired in the reser-
voir section of the RT-DC chip (where applied shear is negligible) by subtracting this value
from the deformation measured in the channel. Subtraction is done by statistical representations
of channel and reservoir measurements and using a bootstrapping approach (Golfier et al., 2017
and Herbig et al., 2018). RT-DC data were analysed using the ShapeOut 0.8.4 software (avail-
able at www.zellmechanic.com). Further analysis was performed using MatLab R2016b and
GraphPad Prism 7. P-values were calculated using the linear mixed model.
B. Viability study
Jurkat cell viability was assessed using the Live/Dead Viability/Cytotoxicity kit for mam-
malian cells (Life Technologies Ltd.) as per the manufacturer’s manual. The flow cytometric
analysis was performed with excitation at 488 nm. Live cells stained with calcein emit green
fluorescence (530/30 bandpass), while dead cells appear red (610/20 bandpass) due to staining
with ethidium homodimer. Cells were analysed on a FACSCalibur machine (BD Bioscience)
immediately after staining, and obtained raw data were analysed using FlowJo V10 CL
software.
C. Cell culture and treatment
1. Sample preparation
a. Jurkat cells. Jurkat cells were cultured in Roswell Park Memorial Institute (RPMI)
medium (ThermoFisher Scientific) supplemented with 10% (v/v) fetal bovine serum (FBS)
(Gibco) in a humidified incubator at 37 C in 5% CO2. Cells from the same batch were col-
lected and when at their exponential growth phase split into fresh cell culture flask to maintain
researched conditions: a control incubated in medium with serum, a sample from complete
medium supplemented with Pluronic F-68, cells incubated in PBS-/- (phosphate buffered saline
without calcium and magnesium, Gibco, cat. 10010023), and PBS-/- containing Pluronic F-68
and incubated for desired times (1, 2, and 3 h) in a humidified incubator at 37 C in 5% CO2.
The chosen time scale is motivated by an approximate time required to perform experiments
using microfluidic systems, ensuring unaffected cell viability for unbiased results (SFig. 2).
Prior to RT-DC measurements, cells were collected by centrifugation at 300 g for 5min and
re-suspended in 0.5% (w/v) solution of methylcellulose at 1 106 cells/ml. To assess the effect
of the Pluronic F-68 concentration, the concentration was adjusted to 0.1%, 0.5%, and 1% (w/
v) and quantified after 3 h incubation. At each time point, cells from both tubes (control and
treated samples) were collected by centrifugation and re-suspended in 0.5% methylcellulose and
immediately taken for measurements in the RT-DC. All obtained data result from three inde-
pendent replicates, from cells of the same cell line coming from different batches.
b. Red blood cells. Packed purified red blood cells (RBCs) from healthy donors stored in a
serum-free buffer were purchased from Cambridge Bioscience Ltd. Cells were stored at 4 C,
and cells from three batches were used for experimental work within a week of collection.
Cells for experiments were counted on a haemocytometer, and the cell density was adjusted to
10 106 cells/ml by addition of an adequate PBS-/- volume (experimental control) or PBS-/-
supplemented with Pluronic F-68 to a 1% (w/v) final concentration. Prepared cells were
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incubated at 4 C prior to measurements on RT-DC, then collected by centrifugation at 500 g
for 5min, and re-suspended in 0.5% methylcellulose.
c. HEK cells. HEK cells were cultured in basal Dulbecco’s Modified Eagle Medium (DMEM)
(ThermoFisher Scientific) supplemented with 10% (v/v) FBS (Gibco) and 1% (v/v) GlutaMAXTM
(ThermoFisher Scientific) in a humidified incubator at 37 C in 5% CO2. Cells from the same
batch were collected for RT-DC measurements by harvesting them into the suspension using
TrypLETM (ThermoFisher Scientific). Prior to the TrypLE treatment, cells were washed twice
with PBS-/-, and an appropriate volume (5ml for a 75 cm2 flask) of TrypLE was added. Cells
were incubated in a humidified incubator at 37 C in 5% CO2 for 5min. After the monolayer dis-
sociation, complete medium containing serum was added to inactivate the TrypLE and wash cells
off the surface of the flask. Next, cells were transferred into a 15ml centrifuge tube, and they
were collected by centrifugation at 300 g for 5min, the supernatant was discarded, and cells
were re-suspended in 0.5% solution of methylcellulose at 1 106 cells/ml. A control containing
serum was collected straight from the cell culture flask. The remaining two samples were cultured
for 1, 2, and 3 h in either (PBS-/-) (serum-free experiment) or PBS-/- supplemented with 1% (w/
v) cell culture grade Pluronic F-68 (ThermoFisher Scientific) (treated sample), incubated for a
desired time in a humidified incubator at 37 C in 5% CO2, and harvested prior to measurements
as described above. All obtained data results from three independent replicates, from cells of the
same cell line coming from different batches.
HEK cells were also examined for cytoskeletal re-arrangements in their adherent and sus-
pended states by examining F-actin. Cells (adherent and harvested in suspension HEK in serum
control, HEK incubated for 3 h in PBS, and PBS supplemented with 1% Pluronic F-68) were
stained for 30min at room temperature against F-actin with Actin Creen 488 Ready Probes
reagents (Life Technologies, cat. R37110). 10min before the end of the incubation time,
Hoechst 33342 (Sigma Aldrich, cat. 14533) was added to a final 10 ng/ml concentration to visu-
alise the cell nucleus. To avoid additional cytoskeletal re-arrangements due to cell preparation
for microscopy, cells after treatment were fixed in 4% paraformaldehyde (PFA) (ThermoFisher
Scientific, cat. 28906). Acquisition was performed on a Leica SP5 SMD (Single Molecule
Detection) confocal laser-scanning microscope using a 63 1.4NA HCX PL Apo oil immersion
objective lens. Actin Creen 488 was excited using a tunable white light laser operating at
488 nm and a pulse rate of 80MHz. Hoechtst 33342 was excited with a pulsed 405 nm laser at
a pulse rate of 40MHz. Emission was detected with a photon multiplier tube (PMT).
III. RESULTS
A. Effect of Pluronic on Jurkat cell size and deformability
1. Time dependency
To understand the short-term effect of the Pluronic F-68 additive on the cell mechanotype,
we measured the size and deformability of Jurkat cells cultured either in cell culture medium
containing serum or phosphate-buffered saline (PBS-/-), and we compared them against cells
whose medium was supplemented with 1% Pluronic F-68. The choice of a serum-free experi-
ment is motivated by our experience with microfluidic systems. Most tissue culture systems
contain serum, which easily clogs microfluidic chips (due to the high protein content), and
therefore, replacing the cell culture medium with PBS-/- for the time of the experiments is a
common practice (McGrath et al., 2014; Lange et al., 2017; and Abd Rahman et al., 2017).
The RT-DC measurements were taken each hour for 3 h. The chosen time-scale was motivated
by an average longevity of experiments in microfluidic systems used in our laboratory.
Figures 1(a) and 1(b) show time-dependent changes in cell deformability. The effect of
Pluronic F-68 was normalised to the untreated control. For both conditions, addition of Pluronic
F-68 causes significant changes after 3 h of addition. The alteration of deformability, expressed
here as differential deformation (DD) (please see materials and methods for details) of cells cul-
tured in serum [Fig. 1(a)], progresses slowly but gradually for the first 2 h, causing initially
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FIG. 1. Effect of Pluronic F-68 on cells of Jurkat cell line mechanical properties was quantified using real-time deformability
cytometry (RT-DC) and flow cytometry. Cells from four conditions: Jurkat cells in serum (green)—cells extracted directly from
tissue culture containing serum; Jurkat cells in serum þ1% (w/v) Pluronic F-68 (gray)—cells cultured in medium containing
serum supplemented with 1% Pluronic F-68; Jurkat cells in PBS-/- (blue)—cells incubated in PBS-/- without serum; and Jurkat
cells in PBS-/- þ1% Pluronic F-68 (red)—cells incubated in PBS-/- supplemented with 1% Pluronic F-68, without serum, were
examined. Deformation was measured every hour for 3 h. (a) and (b) Time-dependent response graphs show mean differential
deformation (DD) values of three experimental replicates. Error bars correspond to the standard error of the mean (SEM). P-
values were calculated using the linear mixed model (*p-value < 0.01, **p-value< 0.001, and n/s ¼ no significant). (c) and (d)
Exemplary contour plots show outlines of assessed populations (more than 4000 events per population) for deformation versus
size (expressed as the projected cell area in lm2) recorded in the measurement channel section of the RT-DC chip. All samples
were examined at a flow rate of 0.04ll/s in a 20  20 lm2 cross sectional RT-DC channel after 3 h of incubation. (e) and (f)
Cell size was assessed using the forward light scatter parameter (FSC-A) measured using a flow cytometer for 10 000 cells.
Receiver Operating Characteristic (ROC) curves were plotted for size expressed as FSC-A. The true positive rate is defined as
the number of control cells measured for a certain size cutoff point and divided by the total number of control cells. The false
positive rate is the corresponding number of Pluronic F-68-treated cells divided by the total number of treated cells for the same
cutoff. The area under the curve (AUC) was calculated to quantify the size overlap between control and treated cells after 3 h.
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slight (>5%), almost negligible (p-value, no significant), stiffening. Incubating cells for 3 h in
the presence of Pluronic F-68 causes significant (p-value <0.01) decreases in cell deformability
( 23%). Specifically, it drops within 3 h from DD¼ 0.0516 0.0017 to DD¼ 0.0396 0.0045
(DD is expressed as the mean of three experimental replicates 6 standard error of the mean,
SEM).
Interestingly, when the medium containing serum is replaced with PBS-/- [control from
Fig. 1(b)], cell deformability drops by  22% from the original DD ¼ 0.0516 0.0017 to DD
¼ 0.0406 0.0015 within less than 15min of medium replacement, and it equilibrates within an
hour at DD¼ 0.0326 0.0016. During the first 2 h, the Pluronic F-68-treated sample and PBS-/-
control are indistinguishable. After 3 h of incubation, the Pluronic F-68-treated sample diverges
and becomes stiffer (DD ¼ 0.0226 0.0023) by  29%.
The RT-DC technique is based on image analysis allowing for the size measurement,
which is expressed as a projected cell area reported in lm2, as shown in the contour plots
[Figs. 1(c) and 1(d)]. Typically, the cell size is obtained from images acquired in the reservoir
section (SFigs. 1 and 3) where the degree of shear is negligible, ensuring the best cell align-
ment. Although accurate, the technique can at times be sensitive to the changes in focus setting.
Hence, rather than reporting the projected cell area, we used flow cytometry to quantify forward
light scatter (FSC-A)—a measurement of the amount of a laser beam that passes around the
cell—providing a relative cell size. Figures 1(e) and 1(f) show the acquired values of FSC-A
for all conditions. To quantify the degree of size overlap, receiver operating curves (ROC) were
generated, and the corresponding area under the curve (AUC) was calculated. Supplementing
the medium with Pluronic F-68 has a negligible effect on cell size, and it remains unchanged
for both cells in serum (AUC¼ 0.52) and cells in PBS-/- (AUC¼ 0.54).
2. Concentration dependency
Recommended poloxamer additive concentrations depend on the purpose and intended
application. Proposed working concentrations for cell culture vary between 0.1% and 1% w/v
(Gigout et al., 2008; Guo et al., 2014; and Tharmalingam et al., 2008). Here, we examined the
effect of different Pluronic F-68 concentrations (0.1, 0.5, and 1% w/v) on Jurkat cells, incu-
bated for 3 h in the supplemented medium with and without serum and compared to untreated
controls.
Figure 2 shows the effect of different Pluronic F-68 concentrations on Jurkat cells in serum
exerted in terms of cell deformability. Lower concentrations (0.1% and 0.5%) do not trigger
changes in cell deformability within the first 3 h of exposure. The cell size (expressed as FSC-
A measured by flow cytometry) remains unaffected as reported in Fig. 2(b) (AUC¼ 0.53 for
1%, AUC¼ 0.50 for 0.5%, and AUC¼ 0.54 for 0.1% Pluronic F-68).
Jurkat cells in PBS-/- [Fig. 2(c)] are slightly more sensitive to the presence of Pluronic
F-68 since small ( 6%) but consistent changes (standard error of the mean SEM¼ 0.0007 for
three replicates of the experiment, p-value < 0.01) are observed after 3 h of exposure to 0.5%
Pluronic F-68. Similar to the previous samples, the cell size remains unaffected for all condi-
tions [Fig. 2(d)].
B. Effect of Pluronic F-68 on RBC size and deformability
In previous works, the effect of Pluronic F-68 on red blood cells (RBCs) was examined for
diseased erythrocytes in sickle anaemia, where it was discovered that Pluronic F-68 minimises
cell-cell adherence and blood viscosity (Smith et al., 1987 and Sandor et al., 2015). Here, we
focused on the impact of Pluronic on mechanical properties, and we compared the deformation
of packed RBCs stored in a serum-free buffer and RBCs treated with 1% Pluronic F-68 over
the course of 3 h. Figures 3(a) and 3(b) demonstrate that the stiffening effect observed for
Jurkat cells, when incubated for a short time (up to 3 h) in poloxamer additives, is also shown
by RBCs, however, to a smaller degree. A decrease in RBC deformation from its original value
DD¼ 0.1646 0.008 is visible after 2 h of incubation (DD¼ 0.1486 0.006). Initially, cell defor-
mation drops by 10% (p-value< 0.01) to reach  16% (DD ¼ 0.1356 0.008,
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p-value< 0.01) after 3 h of exposure to Pluronic F-68. RBCs are not spherical, while in the sus-
pension, they are biconcave discs, and when exposed to shear in laminar flow, they streamline
and assemble the tear-like shape as shown in Fig. 3(c). To assess if exposure to Pluronic F-68
causes changes in the size, RBCs from both conditions at the 3 h time-point were assessed by
flow cytometry for the FSC-A parameter [Fig. 3(d)]. A ROC curve with AUC ¼ 0.52 was gen-
erated to confirm that the cell size is unaffected by short-term exposure to Pluronic F-68.
FIG. 2. Cells of the Jurkat cell line were used to examine concentration-dependent deformability and size alteration caused
by the Pluronic F-68 additive. Cells were incubated for 3 h in medium containing serum and PBS-/- supplemented with
0.1% (yellow), 0.5% (orange), and 1% (grey) Pluronic F-68. (a) and (c) Concentration-dependent graphs show that Jurka
cells response to the increasing concentration of Pluronic F-68 in comparison to untreated control. The data points represent
the mean differential deformation (DD) values of Jurkat cells treated with Pluronic F-68 measured on three separate occa-
sions. The bar graphs represent the standard error of the mean (SEM), and the significance of results was calculated using
the linear mixed model (* p-value < 0.01, ** p-value< 0.001, and n/s ¼ no significant). (b) and (d) To assess if treatment
with Pluronic F-68 causes changes in size, cells were characterised by flow cytometry for the forward light scatter (FSC-A)
for 100 00 cells from each condition. Receiver Operating Characteristic (ROC) curves were plotted for size expressed as
FSC-A. The true positive rate is defined as the number of control cells measured for a certain size cutoff point and divided
by the total number of control cells (green). The false positive rate is the corresponding number of Pluronic F-68-treated
cells divided by the total number of treated cells for the same cutoff. The area under the curve (AUC) was calculated to
quantify the size overlap between control and treated cells. Data for all samples were collected at a flow rate of 0.04ll/s in
a 20  20 lm2 cross sectional RT-DC channel.
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C. Effect of Pluronic F-68 on adherent HEK cells
Human embryonic kidney (HEK) cells are adherent cells commonly used in cell biology
(Stepanenko and Dmitrenko, 2015). Due to the wide-spread application of HEK cells, we used
this cell line to research if there is a short-term (1–3 h exposure) effect of Pluronic F-68 exerted
on adherent cells, using the same methodology as presented above. Deformability of cells cul-
tured in the medium with serum, incubated in PBS-/- and PBS-/- supplemented with 1%
Pluronic F-68, was examined [Figs. 4(a) and 4(b)]. Prior to the measurement, cells were har-
vested into the suspension by enzymatic treatment with TrypLE [Fig. 4(c)]. The enzymatic har-
vest protocol requires serum removal to prevent enzyme inhibition. The serum is removed by
replacing the cell culture medium with PBS-/- and washing with PBS-/- in order to remove
traces of the protein-rich serum. Figure 4(a) shows changes in deformation measured by RT-
FIG. 3. Deformability and size of isolated packed red blood cells (RBCs) treated with 1% Pluronic F-68 (red) were com-
pared to untreated control (grey). Both samples were examined at a flow rate of 0.12ll/min in a 20 20 lm2 cross-
sectional RT-DC channel. (a) Time-dependent alteration in deformability as a response to 1% Pluronic F-68 is presented as
mean differential deformation (DD) values measured on three separate occasions. The error bars are the standard error of
the mean. P-values were calculated using the standardized mixed model (*p-value < 0.01 and n/s ¼ no significant). (b)
Contour plots (for more than 2000 cells from each population) were drawn, presenting cell deformability vs projected cell
area (lm2). (c) Representative images of cells extracted from the channel and reservoir section of the RT-DC chip for cells
incubated for 3 h. (d) To assess if treatment with Pluronic F-68 causes changes in size, cells (10 000 events for each condi-
tion) were characterised by flow cytometry for the forward light scatter (FSC-A). Receiver Operating Characteristic (ROC)
curves were plotted for size expressed as FSC-A. The true positive rate is defined as the number of control cells measured
for a certain size cutoff point and divided by the total number of control cells (green). The false positive rate is the corre-
sponding number of Pluronic F-68-treated cells divided by the total number of treated cells for the same cutoff. The area
under the curve (AUC) was calculated to quantify the size overlap between control and treated cells.
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DC for HEK cells cultured in PBS-/- (red) and PBS-/- supplemented with 1% Pluronic F-68
(blue) for 3 h and compared control cells (green) cultured in the whole cell culture medium.
There was no significant (p-value n/s) change observed between PBS-/- cells (DD¼ 0.029
6 0.0078) and PBS-/- þ 1% Pluronic F-68 (DD¼ 0.0346 0.0058). The most dramatic change
( 63% after 3 h, p-value <0.001) was triggered by replacing the whole medium
(DD¼ 0.0796 0.0093) with PBS-/-. To assess if replacing the cell culture medium with PBS-/-
and PBS-/- supplemented with 1% Pluronic F-68 triggers any changes in size, cells were
assessed by flow cytometry for the FSC-A parameter [Fig. 4(d)]. Despite the dramatic change
in cell deformation caused by replacing the whole medium with PBS/-/, there is no size alter-
ation (AUC¼ 0.52). Similarly, supplementing PBS-/- buffer with 1% Pluronic F-68 does not
contribute to cell size alteration (AUC¼ 0.51).
FIG. 4. Effect of Pluronic F-68 on adherent HEK cell deformability was quantified using real-time deformability cytometry.
Cells from three conditions: HEK cells in serum (green)—cells harvested directly from tissue culture containing serum; HEK
cells in PBS-/- (red)—cells incubated in PBS-/- without serum for 1, 2, and 3 h; and HEK cells in PBS-/- þ1% Pluronic F-68
(blue)—cells incubated in PBS-/- supplemented with 1% Pluronic F-68, without serum, were examined in a 20 20 lm2
cross-sectional RT-DC channel at a flow rate of 0.04ll/s. (a) Time-dependent response graphs show the mean differential
deformation (DD) values of three experimental replicates. Error bars correspond to the standard error of the mean (SEM). P-
values were calculated using the linear mixed model (*p-value < 0.01, ** p-value< 0.001, and n/s ¼ no significant). (b)
Exemplary contour plots show outlines of assessed populations for deformation vs size (expressed as the projected cell area in
lm2) recorded in the measurement channel section of the RT-DC chip for more than 4000 cells. (c) Prior to the measurement,
cells were harvested into the suspension using enzymatic treatment. Representative images obtained at 20 magnification
show the morphology of adherent cells and cells in the suspension. (d) Cell size was assessed by flow cytometry for the forward
light scatter (FSC-A) for 10000 cells from each condition. Receiver Operating Characteristic (ROC) curves were plotted for
size expressed as FSC-A. The true positive rate is defined as the number of control cells measured for a certain size cutoff point
and divided by the total number of control cells (green). The false positive rate is the corresponding number of treated cells
(either in PBS-/- or PBS-/- þ1% Pluronic F-68, respectively) divided by the total number of treated cells for the same cutoff.
The area under the curve (AUC) was calculated to quantify the size overlap between control and treated cells.
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IV. DISCUSSION AND CONCLUSION
In this study, it was demonstrated that Pluronic F-68 alters cell mechanical properties, causing
cell stiffening with no impact on cell size. The short-time (1–3h) effect was examined for cells of the
Jurkat (suspension) cell line, red blood cells, and adherent HEK cells. It was established that cell
deformability undergoes significant alteration within the first hours of exposure to Pluronic F-68, even
at concentrations as low as 0.5% w/v for cells in the suspension without serum. Adherent HEK cells
do not show the stiffening trend as observed for Jurkat cells and RBCs. We speculate that the result
could be explained with the cell preparation protocol since prior to RT-DC measurements (similar to
other common microfluidic applications), HEK cells have to be harvested into the suspension. We
believe that the harvest exerts more dramatic effects than the Pluronic treatment itself. By imaging
HEK cells, we observed that cell detachment is followed by changes in cytoskeleton (SFig. 4), known
to substantially contribute to cell mechanical properties (Walther et al., 2016). More specifically,
when cells adhere to a surface, the F-actin (in green in SFig. 4) spreads, creating angular shapes sur-
rounding the cell nucleus (in blue in SFig. 4). When cells are harvested into the suspension, F-actin
rearranges to maintain a spherical shape, with the characteristic sharp-corners being replaced with
some irregular round local accumulations of F-actin and smooth appearance.
The cell mechanical response to treatment with Pluronic F-68 is relatively small, and due
to Pluronic biocompatible nature, they are physiologically negligible (with no effect on cell
size and viability). However, it must be considered that cell deformability can be significantly
affected by the poloxamer additive and serum removal from the experimental system. It has
been shown that Pluronic F-68 decreases plasma membrane fluidity (Ramirez and Mutharasan,
1990), probably due to its surfactant properties, enabling Pluronic to integrate into the lipid
bilayer of the cell (Maskarinec et al., 2002). Although the exact mechanism underpinning cell
stiffening after exposure to Pluronic F-68 is not known yet, Gigout et al. tracked Pluronic F-68
uptake within Jurkat cells, discovering that fluorescently tagged Pluronic F-68 is continually
transferred into the cell, enclosed in endosomes, and transported alongside the endocytotic path-
way. Based on these results, they suggested that the stiffening effect could be explained par-
tially by the alteration of the cell membrane and cytoplasm properties, as a consequence of the
high Pluronic content accumulated in intracellular vesicles localised across the cytoplasm and
just beneath the plasma membrane.
Cell deformability is gaining recognition as a novel cell state marker. Reduced cell deform-
ability is commonly associated with a pathological phenotype, e.g., in malaria (Hosseini and
Feng, 2012 and Toepfner et al., 2018), sickle-cell disease (Xu et al., 2016), and thalassemia
(Athanasiou et al., 1991). Additionally, deformability is seen as a valuable label-free marker
associated with various cell activities, such as cell cycle regulation (Tsai et al., 1996), differen-
tiation (Lin et al., 2017), metastasis (Ochalek et al., 1988), and leukocyte activation
(Khismatullin, 2009). Many available technologies for deformability analysis [Atomic Force
Microscopy (Jalili and Laxminarayana 2004), microconstrictions (Lange et al., 2015), optical
stretchers (Ekpenyong et al., 2012), micropipette aspiration (Kee and Robinson, 2013), and
magnetic bead twisting (Wang et al., 1993)] require prolonged operational time to gain a rea-
sonable number of measurements. Our findings highlight the importance of seeking high-
throughput technologies and careful consideration of experimental conditions to measure
deformability changes and analyse the mechanical phenotype.
SUPPLEMENTARY MATERIAL
See supplementary material for the RT-DC setup schematic and flow cytometric viability
assay results.
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